Cannabis-Psychosis Causality Boundary

Definition

The cannabis-psychosis causality boundary separates acute cannabis-induced psychotic reactions and population associations with schizophrenia from the stronger claim that cannabis independently causes schizophrenia in otherwise non-vulnerable people.

Current Synthesis

Matthew Hill accepts several risk signals: people with schizophrenia use cannabis at higher rates, adolescent use is associated with later schizophrenia, high-dose THC can produce paranoia or rare acute psychotic episodes, and cannabis may accelerate or worsen disease expression. He nevertheless rejects a simple one-way causal story. Shared predisposition, self-medication, reverse direction, dose, age, product, and genetic liability can all contribute to the observed association.

The practical conclusion is more cautious than the causal conclusion. Uncertain causality is not evidence of harmlessness. The episode advises people with schizophrenia, bipolar disorder, or a first-degree family history of either condition to avoid cannabis. Hill’s “fuel on a fire” analogy treats THC as a possible amplifier or trigger in an already vulnerable system without claiming that the same pathway explains every case.

Key Claims

• Acute cannabis-induced psychotic episodes can occur, though the source describes them as rare.
• Adolescent cannabis use and later schizophrenia are associated at the population level.
• Association alone does not establish that cannabis independently causes schizophrenia.
• Genetic liability and prodromal or self-medication pathways may partly explain directionality.
• Cannabis can still plausibly trigger earlier onset or worsen expression in vulnerable people.
• Schizophrenia, bipolar disorder, or first-degree family history creates an avoidance boundary even while causality remains unsettled.

Evidence

• Acute effects: How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill distinguishes panic, paranoia, and rare acute psychotic reactions.
• Population association: How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill accepts higher cannabis use in schizophrenia and the adolescent-use association.
• Directionality qualification: How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill cites genetic work as more consistent with schizophrenia liability predicting cannabis use than the reverse.
• Clinical caution: How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill advises avoidance for schizophrenia, bipolar disorder, and first-degree family history.

Counterevidence & Qualifications

The episode note does not provide study identifiers, absolute risks, dose-response estimates, age windows, product composition, confounder adjustment, or diagnostic methods. Genetic directionality evidence does not prove that cannabis has no causal contribution, and rare acute episodes are still clinically important. This boundary should prevent causal overstatement, not minimize risk or encourage self-experimentation in vulnerable people.

What Changed

• Created the concept to preserve both the association evidence and the limit on simple schizophrenia-causation claims.

Related Concepts

• Cannabis Dose-Route-Vulnerability Framework - broader framework in which psychiatric history changes the risk profile.
• Psychiatric Functional Diagnosis / 精神科功能受损诊断 - clinical neighbor emphasizing symptoms and function rather than one exposure story.
• Bipolar Disorder - high-risk condition named in the episode’s cannabis-avoidance boundary.
• Medical Risk Management - broader practice of acting cautiously even when causal evidence is incomplete.
• AI Psychosis - separate psychosis-related domain where terminology and causality also require careful boundaries.